Universitätsklinikum Düsseldorf

Hospital


Location: Düsseldorf, Germany (DE) DE

ISNI: 0000000089227789

ROR: https://ror.org/006k2kk72

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

AGO Recommendations for the Surgical Therapy of the Axilla After Neoadjuvant Chemotherapy: 2021 Update (2021) Friedrich M, Kühn T, Janni W, Müller V, Banys-Pachulowski M, Kolberg-Liedtke C, Jackisch C, et al. Journal article, Review article TYK2-Inhibition: Potenzial bei der Behandlung chronisch-entzündlicher Immunerkrankungen (2021) Ghoreschi K, Augustin M, Baraliakos X, Krönke G, Schneider M, Schreiber S, Schulze-Koops H, et al. Journal article, Review article Updated S2k AWMF guideline on obstructive sialadenitis Aktualisierte AWMF-S2k-Leitlinie zur obstruktiven Sialadenitis (2021) Geisthoff U, Al-Nawas B, Beutner D, Günzel T, Iro H, Koch M, Lell M, et al. Journal article, Review article TYK2 inhibition and its potential in the treatment of chronic inflammatory immune diseases (2021) Ghoreschi K, Augustin M, Baraliakos X, Krönke G, Schneider M, Schreiber S, Schulze-Koops H, et al. Journal article, Review article Response to treatment of uncommon EGFR mutations - a retrospective analysis from the German National Network Genomic Medicine Lung Cancer (nNGM) (2021) Janning M, Sueptitz J, Forstreuter A, Albers-Leischner C, Tufman A, Velthaus-Rusik JL, Reck M, et al. Conference contribution Status report on the atopic dermatitis registry TREATgermany Statusbericht zum Neurodermitisregister TREATgermany (2021) Siegels D, Haufe E, Heinrich L, Werfel T, Weidinger S, Schmitt J, Abraham S, et al. Journal article, Review article Elective Discontinuation of Checkpoint Inhibitor Therapy in Patients with advanced Melanoma (2021) Persa OD, Schatton K, Ruebben A, Berking C, Erdmann M, Schlaak M, Mauch C, Steeb T Conference contribution CTLA4 promoter hypomethylation is a negative prognostic biomarker at initial diagnosis but predicts response and favorable outcome to anti-PD-1 based immunotherapy in clear cell renal cell carcinoma (2021) Klümper N, Ralser DJ, Zarbl R, Schlack K, Schrader AJ, Rehlinghaus M, Hoffmann MJ, et al. Journal article Re-Irradiation in head & neck cancer - a pooled analysis of 253 individual cases (2021) Roesch J, Oertel M, Fabian A, Hoeck M, Von Der Gruen J, Loeser A, Suess C, et al. Conference contribution S2k-Leitlinie zur Diagnostik und Therapie des kutanen Lupus erythematodes – Teil 1: Klassifikation, Diagnostik, Prävention und Aktivitätsscores (2021) Worm M, Zidane M, Eisert L, Fischer-Betz R, Foeldvari I, Günther C, Iking-Konert C, et al. Journal article